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Introduction
Cerebral malaria (CM) is a severe neurovascular complication of  Plasmodium falciparum infection charac-
terized by impaired consciousness and seizures, as well as a fatality rate up to 20% even when appropriate 
clinical management is provided (1). In African regions, where disease transmission is high and immunity 
develops after repeated infections, severe malaria primarily affects children under the age of  10. By compar-
ison, in lower transmission settings, both children and adults are susceptible, but the clinical manifestations 
differ across ages (2). In particular, multiorgan complications occur more frequently in adult CM (2, 3), 
and brain swelling is more severe in children (4). The factors contributing to age differences in CM disease 
presentation and brain swelling remain unclear.
A hallmark of  CM is the sequestration of  mature parasitized RBCs (pRBCs) in the cerebral microvas-
culature (5). However, the extent and pattern of  brain histological injury vary by age (3, 6). Brain autopsy 
Cerebral malaria (CM) affects children and adults, but brain swelling is more severe in children. 
To investigate features associated with brain swelling in malaria, we performed blood profiling 
and brain MRI in a cohort of pediatric and adult patients with CM in Rourkela, India, and 
compared them with an African pediatric CM cohort in Malawi. We determined that higher 
plasma Plasmodium falciparum histidine rich protein 2 (PfHRP2) levels and elevated var 
transcripts that encode for binding to endothelial protein C receptor (EPCR) were linked to CM at 
both sites. Machine learning models trained on the African pediatric cohort could classify brain 
swelling in Indian children CM cases but had weaker performance for adult classification, due to 
overall lower parasite var transcript levels in this age group and more severe thrombocytopenia 
in Rourkela adults. Subgrouping of patients with CM revealed higher parasite biomass linked to 
severe thrombocytopenia and higher Group A–EPCR var transcripts in mild thrombocytopenia. 
Overall, these findings provide evidence that higher parasite biomass and a subset of Group 
A–EPCR binding variants are common features in children and adult CM cases, despite age 
differences in brain swelling.
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studies in African children have revealed microvascular leak, fibrin deposits, and thrombosis associated with 
sequestered pRBCs (7–10). By comparison, thrombosis is more variable in adult CM, with levels ranging from 
negligible (6, 8) to high (11). Lumbar punctures and MRI studies indicate that raised intracranial pressure and 
severe brain swelling are associated with fatal pediatric CM (12, 13). By comparison, brain swelling is milder 
and not associated with death in adult patients (4, 14). Nevertheless, MRI studies in both children and adults 
have provided evidence for vasogenic edema resulting from a breakdown of the blood-brain barrier (14–17). 
Collectively, these autopsy and neuroimaging findings reveal heterogeneity in CM features between children 
and adults, despite having in common abundant sequestration of  pRBCs within the brain microvasculature.
Multiple lines of  evidence suggest that sequestered pRBCs might promote a procoagulant state and 
vascular leak through a variety of  processes. For instance, pRBCs induce tissue factor expression on micro-
vascular endothelial cells (18), and parasite products released during pRBC rupture interfere with anti-
thrombin pathways (19, 20) and induce barrier disruption in endothelial cell monolayers (21–23). In addi-
tion, parasite binding variants associated with severe malaria may impair localized vascular homeostatic 
mechanisms (24). Sequestration is mediated by P. falciparum erythrocyte membrane protein 1 (PfEMP1), a 
clonally variant antigen encoded by the var family (25–27). PfEMP1 proteins contain multiple Duffy bind-
ing-like (DBLα/β/γ/δ/ε/ζ) and cysteine-rich interdomain region (CIDRα/β/γ/δ) adhesion domains that 
sometimes can be found in conserved arrays, known as domain cassettes (DC) (28, 29). A dichotomy exists 
in the PfEMP1 family between variants that encode binding activity for CD36 (CIDRα2–6 domains) (30, 
31), a binding property that is associated with mild infections, or endothelial protein C receptor (EPCR) 
(CIDRα1 domains) (24, 32), a binding property associated with severe malaria. While EPCR binders are 
a minor subset in the PfEMP1 repertoire (~12.5% of  var genes per parasite genotype) (28), this subset is 
transcriptionally elevated in severe malaria patients (24, 33, 34). Because EPCR plays a key role in vascular 
homeostasis through activation of  protein C, parasite blockade of  EPCR function may impair antiinflam-
matory, anticoagulant, and barrier-protective pathways (33, 35–37).
Given the age-dependent differences in CM presentation and brain swelling, in-depth studies are needed 
to better understand CM disease etiology. We previously studied a malaria cohort in Blantyre, Malawi, that 
had undergone MRI brain scans and found that comatose children presented with higher plasma levels of 
PfHRP2, a biomarker of  parasite biomass (38), and var transcripts encoding EPCR binders compared with 
children with UM (36). In addition, low circulating platelet levels were the best machine learning feature for 
discriminating comatose children with or without brain swelling (36). Here, to study whether similar factors 
are linked to CM and brain swelling in different human populations and age groups, we investigated a cohort 
of  both pediatric and adult malaria patients from Rourkela, India, stringently characterized using MRI. By 
comparing cohorts from Rourkela and Blantyre (36), we provide evidence for similar parasite biomass and 
adhesion determinants linked to CM and brain swelling in children and adults from Africa and India.
Results
Characterization of  the study population. A total of  951 patients with P. falciparum–positive blood smears were 
enrolled during October 2013 to August 2019 at IGH in Rourkela, India. To evaluate the occurrence of  brain 
swelling in malaria, 131 P. falciparum–infected patients underwent neuroimaging. Brain-scanned patients 
ranged in age from 3 to 70 years and had CM with or without additional severity symptoms (n = 69), severe 
noncerebral malaria (SNCM, n = 31), or uncomplicated malaria (UM, n = 31). Patients with UM were ill 
enough to be admitted at IGH but did not fulfil the World Health Organization (WHO) criteria for severe 
malaria. Of these 131 brain-scanned patients, 92 were excluded from the present study due to prior adminis-
tration of  antimalarials and resultant insufficient RNA levels necessary to examine the parasite var transcripts. 
The remaining 39 patients were selected for our analyses (Figure 1A and Supplemental Table 1; supplemental 
material available online with this article; https://doi.org/10.1172/jci.insight.145823DS1). There were no 
differences in the clinical and laboratory profiles between the var-typed and excluded patients (summarized 
in Supplemental Table 2), except that excluded patients had lower parasitemia (median, var-typed versus 
excluded patients: 66,880 versus 2,730/μL, P = 0.0028) and plasma PfHRP2 levels (median, var-typed ver-
sus excluded patients: 1080 versus 133.61 ng/mL, P < 0.0001). Of the selected patients, 21 had CM (7 with 
exclusively coma, 14 with coma plus other organ complications), 10 had SNCM, and 8 had UM. The final 
study population was composed of  11 children (10 CM, 1 SNCM) and 28 adults (11 CM, 9 SNCM, 8 UM). 
Transcription of  var genes was analyzed by quantitative PCR (qPCR) in 36 patients and by next-generation 
sequencing (NGS) in 22 patients (Figure 1A).
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Consistent with previous observations (2), the presence of multiorgan complications was positively cor-
related with age in the Rourkela cohort (r = 0.45, P = 0.04, Figure 1B). Severe complications included jaundice 
(48% adults, 18% children), acute kidney injury (29.6% adults, 9.1% children), severe anemia (33% adults, 27% 
children), and hyperlactatemia (29.6% of adults, 18% of children). Brain swelling on admission was assessed 
by MRI, using a 1–4 scale (1, no swelling; 2, mild swelling; 3, moderate swelling; and 4, severe brain swelling; 
Figure 1A). Increased brain volume was negatively associated with patient age, and severe brain swelling was 
only present in pediatric patients (r = –0.67, P = 0.0001, Figure 1B). A subset of adult CM cases had mild (27%) 
or moderate (18%) brain swelling. In addition, 33% of adult patients with SNCM had mild brain swelling.
Plasma levels of PfHRP2, a biomarker of parasite biomass, were elevated in patients with CM and SNCM 
compared with UM (Figure 1C, left panel), which is in line with previous reports (38, 39). There was no sta-
tistically significant difference in PfHRP2 levels between pediatric and adult CM (Figure 1C, middle panel) or 
patients with brain swelling (BS+) and without brain swelling (BS–) (Figure 1C, right panel). Thrombocytopenia 
is common in P. falciparum infection (40). Many patients with CM and SNCM had severe thrombocytopenia 
(<50,000 platelets/μL), although platelet levels were not significantly different from hospitalized UM cases (Fig-
ure 1D, left panel). Platelet counts tended to be lower in adult than pediatric CM cases (Figure 1D, middle pan-
el), but there was no difference in platelet levels in cases with and without brain swelling (Figure 1D, right panel).
Characterization of  var sequence diversity in severe isolates by NGS. To date, there has been minimal in-depth 
characterizations of  var transcription in adults or low-transmission malaria settings. To investigate the 
diversity of  var transcripts associated with severe isolates in the Rourkela cohort, we analyzed var transcript 
profiles in 22 patients by NGS of  DBLα amplicons. This short-sequence tag can be amplified from most 
var transcripts by targeting the N-terminal DBLα domain (Figure 2A). This analysis included 19 patients 
with CM (9 children, 10 adults), 2 with SNCM (2 adults), and 1 with UM (1 adult). Each parasite geno-
type encodes approximately 60 var genes, which are expressed in a mutually exclusive fashion and encode 
distinct binding properties (41). The NGS analysis showed a complex population of  circulating parasites at 
the time of  hospitalization, ranging from 4 to 48 unique DBLα tags per patient (Supplemental Tables 3 and 
4), comparable with NGS analysis of  the Malawian pediatric CM cohort (36). Overall, there was minimal 
overlap of  parasite variants between Indian patients (Figure 2B). Whereas the majority of  patients had no 
DBLα sequences in common (cut-off  ≥ 96% nucleotide identity), a few individuals shared between 1 and 4 
DBLα tags (Figure 2B and Supplemental Figures 1 and 2). However, 3 patients from transmission seasons 
2014–2015 had a partial overlap of  expressed DBLα tags (14–16 tags), and 2 patients from transmission 
season 2017 had 11 expressed DBLα tags in common (Figure 2B and Supplemental Figure 1). Larger num-
bers of  shared DBLα tags likely represent patients being infected with the same or a closely related circu-
lating parasite genotype. While shared DBLα tags were sometimes present over more than 1 transmission 
season, none recurred over the full 5-year study period (Figure 2C).
The var gene family is classified into Group A, Group B, and Group C by 5′ upstream sequence and 
chromosomal location (42) and has diverged in PfEMP1 binding properties (43). Of these, a subset of  Group 
A variants and an unusual chimeric B/A variant called DC8 encode EPCR-binding CIDRα1 domains. Here, 
we will refer to these as Group A–EPCR and DC8-EPCR (Figure 2A). A distinct subset of  Group A var genes 
has been associated with rosetting with uninfected RBCs or unknown binding properties and is termed Group 
A–rosetting/unknown. Group B and Group C are associated with CD36 binding. To classify DBLα tags, we 
performed a BLAST search against a library of  513 var genes (Supplemental Table 4) (28, 44). In phylogenetic 
analysis, DBLα tag sequences clustered according to var type — and not according to age group or swelling 
status (Supplemental Figure 2). Notably, despite being a rarer PfEMP1 subset, the most abundant DBLα tags 
belong to Group A–EPCR or DC8-EPCR in 9 of  22 patients (41%) (Figure 2B). However, the dominant tags 
were usually not shared between different patients (compare upper and lower panels, Figure 2B). While the 
Figure 1. Study consort diagram and population characterization. (A) P. falciparum–positive patients underwent brain MRI scans and subjects that under-
went parasite var typing were categorized into CM (coma with or without other WHO-severity criteria, n = 21, children/adults), SNCM (no coma but other 
severe complications, n = 10, children/adults), and UM (no severe complications, n = 8, adults only). MRI-brain scans were scored on a 4-point scale for brain 
swelling. Patient blood samples were collected to measure plasma PfHRP2 levels (parasite biomass biomarker) and for parasite var transcriptional profiling. 
(B) Number of WHO severe malaria complications in patients with CM (left panel). Extent of brain swelling by patient age in patients with CM or SNCM 
(right panel). Missing dots correspond to overlapping patients. (C) Plasma PfHRP2 levels in different patient subsets. Horizontal line represents median. 
(D) Circulating platelet counts in different patient subsets. Horizontal line represents median. Statistical significance in C and D (P < 0.05) was determined 
by a Kruskal-Wallis test corrected for multiple comparisons by the Benjamini, Krieger, and Yekutieli method. Missing dots in C and D correspond to data not 
available. BS+, brain swelling positive; BS–, brain swelling negative.
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top transcript from patient 118 was a Group A–EPCR and shared with 1 other CM patient, the majority of  
shared DBLα tags belonged to Group B and Group C and were not the most abundant transcript per patient 
(Figure 2, B and C). Altogether, the NGS findings indicate that a broad diversity of  var variants is linked to 
CM in the Rourkela cohort.
Analysis of  var typing across ages in CM and brain swelling patients. To complement the NGS analysis 
of  var transcription, we performed qPCR analysis on 36 patients with 24 domain-specific primers tar-
geting transcripts encoding Group B and Group C (CD36 binders) (34), DC8-EPCR, Group A–EPCR, 
Figure 2. NGS analysis of the var repertoire. (A) Schematic representation of PfEMP1/var types with color coding of domain and domain cassettes. The location 
of var primers used to amplify the DBLα amplicon and illustrative var domain primers are shown. (B) Diversity of var transcripts in each patient. Top: Proportion of 
each unique DBLα tag in a patient is indicated by bar size. Identical DBLα tags (≥96% nucleotide identity) shared between patients are indicated by cluster ID color 
code. Identical var1csa DBLα tags are not colored. Bottom: Functional annotation of DBLα tags in patients. Annotation according to var type was done based on 
BLAST searches of each DBLα tag against a database of 513 annotated var culled from refs. 28 and 44. The year of patient enrolment (2014–2018) is shown along 
the top. Adult and pediatric cases and brain swelling status are indicated below the bar graph. Contaminant: no var hits returned. (C) Bubble graph showing shared 
DBLα tags (≥96% nucleotide identity) grouped by var type across the study period (2014–2018). The weighted proportion of the tag in a patient is indicated by 
circle size. Identical var1csa types are shown here. The year of patient enrolment is indicated at the top, with dotted vertical lines demarcating different years.
 
6
R E S E A R C H  A R T I C L E
JCI Insight 2021;6(18):e145823  https://doi.org/10.1172/jci.insight.145823
or Group A–rosetting/unknown (34, 45) (Supplemental Table 5). Compared with patients with UM, 
patients with CM and brain swelling cases had higher transcript levels of  DC5 (Group A, linked to 
CD31/PECAM-1 binding) (46), a primer targeting both DC8-EPCR and Group A–EPCR (DBLα2/
α1.1/2/4/7), and a Group A subset with dual binding to EPCR–ICAM-1 (47) (Figure 3A). However, 
none of  these comparisons reached statistical significance compared with the hospitalized UM group 
(Figure 3A, top and middle panels).
Overall, there was high concordance between the qPCR and the NGS analysis (Figure 3, A–C). 
Whereas individual var transcript levels did not differ between UM and CM cases by var domain typing 
(Figure 3A), both methodologies reported approximately 3 times higher proportions of  Group A–EPCR 
and DC8-EPCR transcripts in patients with CM compared with the genome representation (~30% of  var 
transcripts in patients with CM versus ~12.5% of  PfEMP1 repertoire) (Figure 3, B and C) (28). Notably, 
the summed transcript levels of  all var subsets were 3-fold higher in children compared with adults, after 
correction for parasitemia using transcript levels of  a housekeeping gene (Figure 3D). All categories of  
detected var transcripts were elevated in pediatric cases (groups A, B, and C), with differences reaching sig-
nificance in Group A–EPCR transcripts, Group A and DC8-EPCR transcripts (DBLα2/α1.1/2/4/7),and 
Group A–DC5 (Figure 3A, bottom). Taken together, our analysis shows an elevated proportion of  
EPCR-binding PfEMP1 transcripts in both children and adults with CM, and the total transcript levels of  
all var subsets were higher in children.
Machine learning models of  pediatric CM, adult CM, and brain swelling. To investigate determinants associ-
ated with CM and brain swelling in different human populations and transmission settings, we combined 
data sets from the Rourkela cohort (21 CM, 8 UM) and our previously published Blantyre pediatric CM 
cohort from Malawi (57 CM, 38 UM) (36). Patients in both locations underwent brain swelling assess-
ment through MRI and were quantified for plasma PfHRP2 levels using the same kit, and their PfEMP1 
transcripts were analyzed using a common subset of  19 var domain primers (36). This comparison showed 
that the adult UM control group in Rourkela had higher PfHRP2 levels and lower platelet counts (both 
indicators of  more severe illness) than the pediatric UM control group in Blantyre, who did not necessitate 
hospitalization (Figure 4). The finding likely explains why the Rourkela UM cases had higher EPCR bind-
ing var transcripts and were less distinguishable from CM cases (Figure 3B), similar to our previous findings 
in a different adult Indian cohort in Goa (33).
To study the combined cohorts, we generated random forest (RF) models using PfHRP2 levels, plate-
let counts, and the 19 var domain primers as features. As shown by unsupervised hierarchical clustering, 
the 19 var domains targeted by qPCR show multiple correlations with each other, because some of  the 
primer sets target different domains within the same protein, or specific PfEMP1 variants tend to be 
expressed together (Supplemental Figure 3) (48). An advantage of  RF modeling is that this approach 
mitigates the impact of  multicollinearity associated with var transcription. RF models were trained on 
different patient subsets. In some RF models, patients with UM were used as the control outgroup to 
compare between patients who differed the most in disease spectrum (CM versus UM). Other RF models 
focused on the subpopulation of  comatose patients to study whether specific features were more closely 
associated with brain swelling (CMBS4–2 [brain swelling score = 2–4] versus CMBS1). RF models trained 
with either PfHRP2 or var transcripts alone performed well on unbiased out-of-bag predictions measured 
by receiver operating characteristic (ROC) curve and 95% CIs (Supplemental Figure 4). On their own, 
PfHRP2 levels and var transcripts (19 var domain features) discriminated patients with CM from patients 
with UM in the combined (Supplemental Figure 4) or individual cohorts (Supplemental Figure 5). By 
comparison, neither was able to classify the presence of  brain swelling within patients with CM (CMBS+) 
(Supplemental Figure 4), indicating that high parasite biomass and specific parasite adhesion types were 
common to patients with CM at both sites, but these features did not discriminate the presence of  brain 
swelling. Whereas platelet count was an important feature for predicting the occurrence of  severe brain 
swelling in children with CM from Blantyre, it performed poorly in the Rourkela cohort or the combined 
data set (Supplemental Figure 5). This is likely due to the high prevalence of  severe thrombocytopenia 
in adult cases from Rourkela, irrespective of  CM status and brain swelling (Figure 1D and Figure 4B).
A combination of parasite biomass, var expression profiles (19 var domain features), and platelet levels had 
the strongest predictive performance in CM versus UM models (Figure 5 and Supplemental Figure 4). The 
top-ranking features in the CM model (CM versus UM: AUC, 0.87 [95% CI, 0.80–0.94]) were high PfHRP2 
levels and high expression of CIDRα1.6 Group A–EPCR var transcript, as determined by the mean decrease in 
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classifier accuracy (MDCA) when the feature in question was removed from the model (Figure 5A, left panel). 
The third ranked feature was platelet counts, followed by Group A–EPCR var transcripts (DBLα1.7 of DC13). 
The significance of each feature and multiple-comparison correction was determined by the mProbes algorithm 
(49). Likewise, in an RF model that focused on the subset of comatose patients with brain swelling (CMBS+ ver-
sus UM: AUC, 0.91 [95% CI, 0.85–0.97]), both high PfHRP2 and low peripheral platelet counts were the top 
predictive features (Figure 5, A and B). In addition, transcripts encoding Group A–EPCR variants (CIDRα1.5, 
CIDRα1.6, CIDRα1.7, and DBLα1.7 of DC13) and DC8-EPCR var transcripts (DBLα-CIDRα of DC8 and 
CIDRα1.8) were statistically significantly increased in the model comparing CMBS+ with UM. Overall, high 
parasite biomass, multiple subsets of Group A–EPCR, and low platelet counts were key determinants of CM 
and brain swelling in the RF model comparisons to UM cases.
By comparison, the same 3 features were unable to distinguish the presence or absence of  brain 
swelling in patients with CM (CMBS4–2 versus CMBS1: AUC, 0.64 [95% CI, 0.44–0.85]; CMBS4 versus 
CMBS1: AUC, 0.67 [95% CI, 0.48–0.91]) (Figure 5B and Supplemental Figure 4). The addition of  WBC 
count and lactate improved the predictive performance of  an RF model comparing the 2 extremes of  
Figure 3. Characterization of parasite var transcript profiles by qPCR analysis. (A) Tukey box and whisker plots showing var domain transcript expression in CM 
(n = 19) and UM (n = 8) patients (top), brain swelling patients (BS+, score > 1, n = 16) (middle), as well as pediatric (n = 9) and adult (n = 12) CM and/or BS cases. 
Individual or summed primer groups (#) are shown: DC8# (CIDRα1) = CIDRα1.1, CIDRα1.8a, and CIDRα1.8b (n = 3); Group A# (CIDRα1) = CIDRα1.4/6, CIDRα1.5a, 
CIDRα1.5b, CIDRα1.6, CIDRα1.7 (n = 5); Group B/C# = DBLα0.1, DBLα0.6/9, CIDRα2/3/5/6/7/9/10, CIDRα2.2, and DBLα0.16 (n = 5). The horizontal line is the 
median, and boxes indicate quartiles. Outliers are indicated as circles. Significance was determined by Mann-Whitney U test. *P < 0.05. (B) Stacked bar graph 
showing functional annotation of DBLα tags in pediatric and adult patients measured by NGS. See also Figure 2. (C) Left: Proportion of var subgroup abundance 
in 7 annotated reference genomes (28). Right: Proportional expression of var subgroups measured by qPCR and NGS across patient subgroups in CMBS+ (n = 8), 
adult CM (n = 8), adult BS+ (n = 5). (D) Average of the summed var transcript levels measured by qPCR (var Tu) for each var subtype across patients in (C).
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brain swelling in patients with CM (CMBS4 versus CMBS1: AUC, 0.73 [95% CI, 0.54–0.92]). In this RF 
model, patients with CM with severe brain swelling were distinguished from patients with CM with 
no brain swelling by higher transcription levels of  a Group A–rosetting/unknown variant (CIDRδ of  
DC16) and a Group A–EPCR binding variant (CIDRα1.7), as well as lower platelet counts, lower lac-
tate concentrations, and lower transcription levels of  a Group B/C var gene (DC19) (Supplemental Fig-
ure 4B). However, none of  these top-ranked features had statistical significance on their own in the RF 
model after correction for multiple comparisons. In general, the RF models performed similarly in the 
combined cohorts and within the Malawi cohort (Supplemental Figure 5), reinforcing the importance 
of  high PfHRP2 levels and Group A–EPCR var transcripts in all patients with CM.
To investigate age differences in var gene expression in brain swelling, RF models were trained on the 
pediatric cohort from Blantyre (CM versus UM) and then used to make blind predictions of  adult and pedi-
atric patients with CM in Rourkela (Figure 6A). An RF var-only model trained in Blantyre failed to discrim-
inate children with brain swelling from UM cases (AUC, 0.68 [95% CI, 0.41–0.95) and performed poorly on 
adult patients with CM in India (AUC, 0.41 [95% CI, 0.1–0.72]). However, the addition of  PfHRP2 levels 
and platelet counts improved the predictive performance of  the models that predicted adult (AUC, 0.67 [95% 
CI, 0.34–0.93]) and pediatric (AUC, 0.75 [95% CI, 0.49–1]) CM with brain swelling in India (Figure 6A). 
The poorer performance in adults is likely due to decreased var transcript levels and lower platelet counts in 
adult CM cases (Figure 3, A and D). To further clarify the relationship of  Group A–EPCR var transcripts in 
children and adult patients with CM, var transcript levels were plotted in the 2 cohorts. There are 4 types of  
Group A–EPCR subsets (DBLα1.7-CIDRα1.4 of  DC13, CIDRα1.5, CIDRα1.6, and CIDRα1.7) assessed 
by our primer sets. Whereas all 4 Group A–EPCR binding var transcripts were elevated in Malawi CM cases, 
the DBLα1.7 (DC13) and CIDRα1.7 were more commonly elevated in the India cohort (Figure 6B). Thus, 
a subset of  Group A–EPCR var transcripts was elevated in both children and adult CM cases, especially 
compared with children UM cases in Malawi. Overall, these findings indicate that some Group A–EPCR var 
transcripts and parasite biomass are elevated in CM in both children and adults.
Figure 4. Measurement of plasma PfHRP2 levels and circulating platelet counts in the Malawi and India cohorts. (A) Plasma PfHRP2 concentration 
across patient groups in Malawi (pediatric CM [n = 58], pediatric UM [n = 36]) and India (adult UM [n = 8], adult SNCM [n = 9], adult CM [n = 7], pediatric 
CM [n = 9]). Horizontal line represents median, and boxes represent interquartile range. Significance was determined by FDR-adjusted Wilcoxon P values. 
(B) Circulating platelet counts across patient groups in Malawi (pediatric CM [n = 58], pediatric UM [n = 32]) and India (adult UM [n = 7], adult SNCM [n 
= 8], adult CM [n = 9], pediatric CM [n = 8]). Horizontal line represents median, and boxes represent interquartile range. Significance was determined by 
FDR-adjusted Wilcoxon P values. Swelling score is indicated with a color scale, and age group and severity are indicated with schematic diagrams.
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Machine learning models of  patients with CM with mild or severe thrombocytopenia. Although platelet counts 
ranked as an important feature for classifying CM and brain swelling in all models (Supplemental Figure 5, 
right), the extent of  platelet loss varied between CM cases. Because nearly all CM cases from both cohorts had 
higher parasite biomass (PfHRP2 levels > 1000 ng/mL (Supplemental Figure 6, A and B), this suggests that 
brain swelling can occur in the presence of  mild or severe thrombocytopenia. To further investigate this find-
ing, patients with CM from the combined data set were classified into mild thrombocytopenia (CM>P [periph-
eral platelets > 50,000/μL]) and severe thrombocytopenia (CM<P [peripheral platelets < 50,000/μL]), and RF 
models were trained to discriminate these groups from patients with UM. Whereas patients with CM with 
mild thrombocytopenia were characterized by moderately high PfHRP2 levels and elevated levels of  multiple 
Group A–EPCR var transcripts (CIDRα1.5, CIDRα1.6, and DBLα1.7-DC13) (AUC, 0.82 [95% CI, 0.74–
0.91]) (Figure 7A, left panel; Figure 7B), only extremely high PfHRP2 levels discriminated patients with CM 
Figure 5. Machine learning analysis of CM and brain swelling in the combined India and Malawi cohorts. (A) Random forest models were trained on 
different patient subsets: CM versus UM (left) and brain swelling versus UM (right) that combine patients from Rourkela and Blantyre. Each individual bar 
represents the predictive performance of the feature in the model ordered by predictive importance (measured by MDCA). Features include: circulating 
platelet levels (platelets), plasma PfHRP2 concentration (PfHRP2), and var domain transcriptional units. Positive MDCA scores indicate higher presence of a 
feature in CM or patients with brain swelling, and vice versa. Asterisks indicate that these features showed significant difference between groups measured 
by mProbes algorithm (family-wise error rate [FWER] ≤ 0.2). (B) Receiver operating characteristic (ROC) curves of CM model (CM versus UM), CM with brain 
swelling model (CMBS+ versus UM), brain swelling within patients with CM (CMBS2–4 versus CMBS1), and severe brain swelling within patients with CM (CMBS4 
versus CMBS1). Area under the ROC curve (ROC AUC) and accompanying 95% CI in parentheses are indicated in the ROC plot legend for each model.
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with severe thrombocytopenia from patients with UM (AUC, 0.92 [95% CI, 0.86–0.98]) (Figure 7A, middle 
panel; Figure 7B). The same differences in parasite biomass and adhesion types were observed when the mild 
and severe thrombocytopenia CM groups were compared in an RF model (AUC, 0.67 [95% CI, 0.54–0.80]) 
(Figure 7A, right panel; Figure 7B). Consistent with RF modeling, Group A–EPCR binding var transcripts 
were elevated in both the mild and severe thrombocytopenia groups compared with UM cases, although they 
tended to be expressed at higher levels in the mild thrombocytopenia group, although there is no statistically 
significant difference (Figure 7C). In addition, platelet counts were inversely correlated to plasma PfHRP2 
levels at both sites (children: ρ = –0.66, P = 3.1 × 10–13; adults: ρ = –0.53, P = 0.013)(Supplemental Figure 6, A 
and B), accounting for the stronger linkage between parasite biomass and severe thrombocytopenia.
Likewise, in an RF model that specifically focused on the subset of  patients with CM with brain swell-
ing, all 4 Group A–EPCR var transcripts (DBLα1.7-DC13, CIDRα1.5, CIDRα1.6, and CIDRα1.7) and 
a primer recognizing Group A dual EPCR and ICAM-1–binding parasites strongly discriminated brain 
Figure 6. Cross-prediction of patients with CM in India from RF models trained on Malawi patients. (A) RF models were trained and parameterized using 
Malawi data sets only with var expression data alone or var in combination with PfHRP2 and platelet levels prior to predicting on Rourkela patients. ROC curves 
illustrating blind predictive performance of random forest models that classify brain swelling patients (CMBS+ versus UM) stratified by pediatric and adult patients 
in Rourkela. ROC AUC and accompanying 95% CI in parentheses are indicated in the ROC plot legend for each model. (B) Transcripts levels of Group A–EPCR var 
transcripts (DBLα1.7 of DC13, CIDRα1.5, CIDRα1.6, CIDRα1.7) in UM, SNCM, and patients with CM from Malawi (pediatric CM [n = 60], pediatric UM [n = 38]) and 
India (adult UM [n = 8], adult SNCM [n = 9], adult CM [n = 9], pediatric CM [n = 9]). Horizontal lines represent median, and boxes represent interquartile range.
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Figure 7. Machine learning models and individual contribution of parasite biomass and Group A–EPCR variants in patients with CM with mild or 
severe thrombocytopenia in Malawi and India. (A) Bar graphs representing the importance of parasite factors in random forest models that classify 
patients with CM with different degrees of thrombocytopenia (mild > 50,000 platelets/μL; severe < 50,000 platelets/μL). Left: Patients with CM with 
mild thrombocytopenia versus UM. Middle: CM with severe thrombocytopenia versus UM. Positive MDCA (left and middle graphs) indicate greater 
presence in CM than in patients with UM. Asterisks show significant difference between groups measured by mProbes algorithm ([FWER] ≤ 0.2). 
Right: Patients with CM with mild thrombocytopenia versus CM with severe thrombocytopenia. Positive MDCA indicates higher association in CM 
with mild thrombocytopenia, and negative MDCA indicates higher association in CM with severe thrombocytopenia. Features include: plasma PfHRP2 
concentration (PfHRP2), and var domain transcriptional units. (B) ROC curves showing the predictive performance of each model. Performance is 
measured by AUC, indicated in the legend with 95% CI in parentheses. (C) Transcripts levels of Group A–EPCR (DBLα1.7 [DC13], CIDRα1.5 and CIDRα1.6) 
in patients with CM with mild thrombocytopenia (CM>P; peripheral platelets > 50,000/μL; Malawi n = 33, India n = 7), CM with severe thrombocytopenia 
(CM<P; peripheral platelets < 50,000/μL; Malawi n = 27, India n = 20), and combined UM from India and Malawi (Malawi n = 38, India n = 8). Horizontal 
lines represent median, and boxes represent interquartile range. Significance was determined by FDR-adjusted Wilcoxon P values.
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swelling patients with mild thrombocytopenia from patients with UM (AUC, 0.91 [95% CI, 0.88–0.98]). 
However, PfHRP2 was the most discriminating feature between severe thrombocytopenic and patients with 
UM (AUC, 0.91 [95% CI, 0.83–0.98]) (Supplemental Figure 6, B–D). Taken together, our findings indicate 
that patients with CM with mild or severe thrombocytopenia were distinguished by parasite biomass and 
Group A–EPCR binding var transcripts from patients with UM, although both features were elevated in all 
patients with CM compared with UM cases.
Discussion
Studies to understand the molecular determinants of  CM have mostly focused on African pediatric 
populations (50). However, disease presentation differs by age, so it is important to study both children 
and adults. In this work, we investigated molecular mechanisms linked to brain swelling in CM across 
age groups and transmission settings by comparing patients from India, where CM occurs in all age 
groups, and Malawi, where CM is predominantly a pediatric disease. These 2 cohorts are among the 
few in the world to undergo MRI scanning for rigorous brain swelling evaluation in CM, allowing the 
unique comparative analysis presented here.
Previous findings have established that parasite biomass (51, 52), and EPCR-binding var transcripts 
(24, 34, 36, 45, 53, 54) play an important role in pediatric CM. However, much less is known about how 
parasite adhesion traits influence disease presentation in adults and non-African populations. To reduce 
confounding variables when comparing between cohorts, similar approaches were used to assess parasite 
biomass (plasma PfHRP2 levels) and adhesion types at both sites. Regarding the control groups in the 2 
cohorts, adult patients with UM in India had higher PfHRP2 levels and lower platelet counts than children 
UM cases in Malawi, indicating they were on the sicker end of  the malaria disease spectrum than the 
Blantyre cohort. The difference is likely because all of  the adult UM cases in Rourkela required hospital-
ization, even though they were classified as UM based on the absence of  WHO severe malaria criteria. 
By comparison, the control group in Malawi was recruited from the outpatient ward. The observation 
that the Rourkela control group was sicker may account for some differences when comparing within 
and between the 2 cohorts. While plasma PfHRP2 levels distinguished Indian patients with WHO sever-
ity criteria, consistent with the finding in other work that parasite biomass is linked to disease severity 
(38), this plasma biomarker did not differ between comatose children and adults in India, suggesting that 
age-specific differences in brain swelling are not merely a consequence of  different parasite burdens. To 
study the var adhesion types linked to CM and brain swelling, we performed NGS of  DBLα amplicons and 
transcriptional profiling with var domain–specific primers. Both methodologies detected an increase in the 
proportion of  EPCR-binding var transcripts compared with their genome abundance. Deep sequencing 
of  parasite var tags showed a broad diversity of  EPCR-binding var sequences in Indian patients with CM, 
even though it is a low malaria transmission setting. By var domain typing, all 4 types of  Group A–EPCR 
subsets (CIDRα1.4/1.5/1.6/1.7) were top var features in CM models from the combined cohorts. Whereas 
all 4 Group A–EPCR subsets were transcriptionally elevated in Malawi children CM cases, some were 
less common in the Rourkela cohort. The DBLα1.7-DC13 subset and the CIDRα1.7 subset, which was 
previously linked to severe brain swelling and fatality in Malawi (36), were frequent in Rourkela CM cases. 
Overall, our analysis implicates multiple subsets of  Group A–EPCR binding transcripts in CM, although 
there may be age and geographical variation that remain to be investigated. Additionally, DC8-EPCR bind-
ing var transcripts were top features in some RF models that focused on subpopulations of  CM patients that 
differed in the extent of  brain swelling or thrombocytopenia. Previous findings suggest that both Group 
A–EPCR and DC8-EPCR variants can inhibit the homeostatic and probarrier EPCR-APC pathway in the 
cerebral vasculature (33, 35, 55, 56). Taken together, our results strongly reinforce the importance of  para-
site biomass and elevated EPCR-binding var transcripts in CM pathogenesis.
The major age-specific differences seen in this study were substantially lower parasite var transcript lev-
els and more severe thrombocytopenia in adult CM cases (summarized in the Figure 8 model). It remains 
to be established whether lower var transcription translates into reduced PfEMP1 surface expression. How-
ever, it has been hypothesized that parasites can switch between low or high PfEMP1 expression states 
to avoid immune detection (57). Recent evidence suggests that factors such as febrile temperature and 
lactate levels may modify PfEMP1 surface display or transcripts involved in forming the cytoadhesion com-
plex (58–62). Therefore, it is interesting to speculate that differences in var transcript levels could relate to 
age-specific differences in the host response, but this remains to be investigated (59, 60, 62).
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Our study suggests there may be interactions between platelets, parasite biomass, and specific parasite 
variants in CM disease etiology (modelled in Figure 8B). Whereas Group A–EPCR-binding var transcripts 
were more prominent in the mild thrombocytopenia patient subset, patients with severe thrombocytopenia 
had higher parasite biomass. Thus, parasite biomass and parasite adhesion types may make different contri-
butions to disease progression in patients with CM with mild versus severe thrombocytopenia. Along with 
brain histological findings (6–11, 63), our findings add to accumulating evidence for different causal path-
ways of  endothelial dysfunction and brain swelling in CM. Activated platelets have long been suspected to 
play an important role in the pathogenesis of  CM: they accumulate in the cerebral microvasculature in fatal 
pediatric CM cases (64), can bind to endothelial cells and provide receptors for PfEMP1 initially absent 
from microvascular beds (65), form clumps with pRBCs (66, 67), and — through these 3 mechanisms  — 
may aggravate microvascular obstruction (68). Conversely, platelets can also directly inhibit parasite growth 
(69, 70), and malaria-associated thrombocytopenia is partly a consequence of  the protective mechanism of  
platelet adhesion to pRBC (71, 72). Given the difference in brain-sequestered platelets in children and adult 
CM cases (6), platelets could be a causative agent of  CM pathology or a biomarker for other inflammatory 
processes. There are numerous interactions between platelets, neutrophils, and monocytes in coagulation 
and vascular dysfunction. For instance, platelet counts are inversely correlated with extracellular histone 
levels in the Malawi cohort, and extracellular histones promote both procoagulant and barrier-disruptive 
pathways (22). Additionally, activated neutrophils, a source of  extracellular histones, are linked to CM 
severity in the Malawi cohort (73, 74). The phenotypes and effector functions of  platelets are modified by 
microvesicles and extracellular histones released by injured cells (75, 76) and neutrophils (77). Consequent-
ly, interactions between platelets and extracellular histones in cerebral microvessels may amplify localized 
coagulation and inflammatory processes (7, 63). These findings raise the possibility for divergent contribu-
tions of  parasite biomass and Group A–EPCR binding variants in disease etiology of  patients with CM 
with mild or severe thrombocytopenia.
Figure 8. Illustrated summary of the main study findings. (A) Features associated with brain swelling in children and 
adults. (B) Features associated with brain swelling in patients with CM with mild or severe thrombocytopenia.  
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A limitation of  the present study is that, despite using the WHO criteria to diagnose patients with UM 
in Rourkela, subjects were enrolled after admission to the hospital. It is therefore plausible that patients 
with UM in our Indian setting were sicker than those with milder infections in Malawi, who did not 
require hospitalization. Additionally, we did not include a pediatric UM group in Rourkela because of  
the challenges associated with performing a 35-minute MRI scan on noncomatose children. Lastly, we 
applied RF models due to their ability to assess variable importance even with multicollinearity of  var 
primers. However, logistic or linear regression modeling could have the additional useful property of  fit-
ting coefficients, reflecting how a change in var gene expression or other variables affects the likelihood of  
CM. Despite these limitations, this is the first study, to our knowledge, to analyze determinants of  CM in 
a cohort of  Indian patients that underwent MRI for brain swelling assessment.
Overall, our findings provide evidence that high parasite biomass and elevated EPCR-binding var transcripts 
are common parasite determinants of CM pathogenesis in both children and adults. Taken together, they further 
strengthen the role of parasite biomass as a pivotal pathogenic mechanism in CM and support the hypothesis 
that restoring normal function of the cytoprotective APC-EPCR signaling pathway may represent a promising 
therapeutic avenue for patients with CM.
Methods
Rourkela patients and samples. Individuals were enrolled between October 2013 and August 2019 at IGH, 
a tertiary-level healthcare establishment owned by the Steel Authority of  India Limited in Rourkela, 
India. Informed consent or assent were obtained from all study patients or their legal guardians prior 
to inclusion in the study. All malaria patients were treated according to the national drug policy of  the 
Government of  India (78), as detailed elsewhere (15). A physical examination was conducted upon 
admission at IGH, and clinical data were recorded and monitored on standardized case report forms. An 
age cut-off  of  16 was used to separate children from adults in our cohort, based on previously published 
results demonstrating that the peak of  total brain volume is reached at 15.2 years (79). Whole blood was 
collected in BD Vacutainer CTAD tubes (Becton Dickinson) containing a mixture of  sodium citrate, the-
ophylline, adenosine, and dipyridamole. Samples were immediately centrifuged at 1500g for 15 minutes 
before pelleted RBC were collected, mixed with TRIzol (Invitrogen, ratio of  1:9) and stored at –80°C 
until batch processing for RNA extraction.
Laboratory and clinical diagnosis for malaria. Falciparum malaria infection was confirmed by P. falciparum 
histidine-rich protein II antigen detection–based rapid diagnostic tests (SD Bioline, Standard Diagnostics), and 
standard microscopic examinations of Giemsa-stained thick and thin smears were carried out to corroborate 
species identification and assess parasitemia. All enrolled individuals were blood smear positive for P. falci-
parum. Results from routine hematological and biochemical analyses were also taken into consideration for 
the diagnosis of severe malaria. Patients were classified as CM, SNCM, or UM based on WHO severe malaria 
criteria: (a) coma (Glasgow coma score < 11 for adults and a Blantyre coma score ≤ 2 for children), (b) severe 
malarial anemia (Hb < 7 g/dL for adults and < 5 g/dL for children), (c) jaundice (bilirubin > 3 mg/dL), (d) 
acute kidney injury (serum creatinine > 3 mg/dL), and (e) hyperlactatemia (lactate > 5 mmol/L).
Assessment of  brain swelling and brain volume quantification. MRI examinations were performed using a 
1.5T Siemens Symphony MRI scanner (Siemens) as described elsewhere (15). The degree of  brain swell-
ing was assessed on T2w images and graded by a neuroradiologist blinded to the clinical classification of  
patients, using a 4-point score according to the degree of  cortical swelling and sulcal effacement: 1, no 
brain swelling; 2, mild brain swelling characterized by cortical swelling and preserved sulci; 3, moderate 
brain swelling with more pronounced cortical swelling and narrowing of  adjacent cerebrospinal fluid-filled 
sulci; and 4, severe brain swelling defined by complete sulcal effacement (Figure 1A). Similar definitions of  
brain swelling were done in the Malawi cohort (36) with the 8-point scale converted to the 4-point swelling 
scale as follows: no brain swelling (swelling scores 1–3 = 1); mild (swelling score 4 = 2); moderate (swelling 
scores 5–6 = 3); severe (swelling scores 7–8 = 4).
Malawi cohort. The Malawi cohort was previously described (36). Both patients with CM or UM were 
recruited from Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi. Patients with CM were 
admitted to the Research Ward within QECH. The CM group included children between the ages of  6 
months and 12 years and met the WHO classification of  CM for P. falciparum parasitemia, a Blantyre coma 
score ≤ 2, and exclusion of  other identifiable causes of  coma. UM children presented to the Accident and 
Emergency Pediatric Department at QECH. Inclusion criteria for UM cases were children 1–12 years old, 
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history of  fever, normal mental health status as measured by Blantyre coma score, peripheral P. falciparum 
parasitemia, and no overt signs of  compromised health, malnutrition, or progression to severe malaria.
Parasite biomass quantification. Plasma levels of  PfHRP2 were measured to quantify total parasite biomass 
(38), using a commercially available ELISA kit (Malaria Ag CELISA kit, catalog KM2, Cellabs). Analyses 
were performed according to the manufacturer’s instructions, in duplicate for each patient, and absorbance 
was read at 450 nm using a Multiskan Spectrum ELISA plate reader (Thermo Fisher Scientific).
RNA extraction and cDNA synthesis. The pRBC-TRIzol cryopreserved tubes were thawed on ice, and total 
RNA was extracted using the RNeasy micro kit (Qiagen), following the manufacturer’s instructions. cDNA 
was then generated using the MultiScribe reverse transcriptase (Thermo Fisher Scientific). A total of  300 
μL cDNA was synthesized per patient sample.
Transcriptional profiling of  var by qPCR. We selected a combination of degenerate primers that specifically 
cover Group A and EPCR binding domains (45), CD36 binding domains (34), and dual EPCR–ICAM-1 
PfEMP1 binders (47). qPCR was carried out using 5 μL of cDNA template per reaction well, along with Power 
SYBR Green PCR Master Mix (Thermo Fisher Scientific) and the specific primers in an ABI 7500 Fast Real 
Time PCR system (Applied Biosystems). PCR cycle amplification parameters included an initial denaturation 
step at 95°C for 15 minutes, followed by 40 cycles of denaturation for 30 seconds at 95°C, annealing for 40 
seconds at 50°C, and extension for 50 seconds at 65°C. Data acquisition was enabled after the extension step 
of each amplification cycle followed by a final extension step of 40 seconds at 68°C and a melt-curve analysis. 
Levels of var transcription were determined by calculating the relative quantification of the average expression 
of adenylosuccinate lyase and seryl-tRNA synthetase housekeeping genes (ΔCt var_primer = Ct var_specific 
primer – Ct average_housekeeping primers). Transcript levels of var domains were represented as transcript 
units (Tu), which were calculated as: Tu = 2(5−ΔCt) (34). The cut-off  Ct (average of the housekeeping genes) for 
inclusion in analysis was < 31.
NGS library preparation and sequencing. DBLα tag libraries from 22 patients (19 CM, 2 SNCM, 1 UM) 
were prepared as described previously (36) with some modifications. DBLα tags were PCR amplified from 
cDNA in 26–41 cycles using the previously published varF_dg2 and brlong2 primers (34) with the addition 
of  5′ and 3′ MiSeq adaptor sequences (5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGG-
CAMGMAGTTTYGCNGATATWGG-3′ and 5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGA-
CAGTCTTCDSYCCATTCVTCRAACCA-3′) at a final concentration of  0.6 μM. The following PCR con-
ditions were used: 98°C for 45 seconds, 98°C for 10 seconds, 50°C for 20 seconds, 68°C for 40 seconds, and 
72°C for 7 minutes. Amplicons were purified using SPRIselect magnetic beads (Beckman-Coulter) and were 
used as a template for the next round of  PCR amplification, achieved in 10 cycles using Nextera P7 and P5 
index primers (Illumina) and the PCR conditions described above. Following amplicon purification, libraries 
were quantified by qPCR (KAPA library quantification kit; Kapa Biosystems) on the StepOnePlus Real-Time 
PCR System (Applied Biosystems) and pooled in equimolar amounts to a concentration of  4 nM. The pooled 
library was then denatured according to Illumina MiSeq instructions. A similarly denatured PhiX control 
library was added at a final concentration of  40% to compensate for the AT richness of  P. falciparum. The final 
sample was sequenced using a 600-cycle v3 kit on the MiSeq Sequencer (Illumina).
Processing of  DBLα tag sequences. Sequences were processed largely as described previously (36, 80), with 
some modifications. Briefly, amplicon sequences were reconstructed by assembly of forward and reverse reads 
using FLASH (81), with removal of nonoverlapping reads. Primer and adaptor sequences were trimmed from 
assembled reads, and any reads with missing primer sequences were discarded using Cutadapt (82). Sequences 
were deduplicated (while keeping track of duplicate counts), and sequences with low-confidence base calls (N) 
were discarded using FASTX-toolkit (http://hannonlab.cshl.edu/fastx_toolkit) (83). Reads from each patient 
were clustered using VSEARCH version v2.9.1 (84) at a 96% nucleotide identity cut-off, producing the final 
processed data set consisting of centroid sequences with their associated abundance (number of times observed 
in the raw data set). To identify the DBLα tags shared among patients, centroids from every pair of individual 
patient data sets were further clustered (using VSEARCH version v2.9.1) at a 96% nucleotide identity cut-off. 
Centroid sequences representing clusters with < 50 source sequences were excluded from further analyses (83).
Functional annotation of  DBLα tags. DBLα tags were assigned a var type based on sequence similarity 
determined by BLAST searches (85) against a custom library of  513 annotated var genes (28, 36, 44). 
BLAST results for the top 5 hits in each search were then used to generate a cumulative score derived from 
E-values (sum of  –log10[E value]) for each var type (e.g., groups B and C, DC8-EPCR). The best-scoring 
var type was assigned to each DBLα tag.
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Database accessibility of  sequences. All DBLα tag sequences have been submitted to GenBank, and accession 
numbers (MW014366 – MW014807) are in Supplemental Table 4.
Statistics. Univariate analyses were performed using GraphPad Prism v8 for Windows and R. Differ-
ences between groups were calculated using a 2-tailed t test or a 2-tailed Mann-Whitney U test. Correlations 
between variables were evaluated using Spearman’s rank correlation coefficient. Differences in CM/swell-
ing scores between samples grouped by binary thrombocytopenia and parasitemia status were assessed by 
the χ2 test. Machine learning analyses were performed using R version 3.6.1. All Rourkela samples and 
Malawi samples with < 25% of  var gene primers missing/below the limit of  detection were included, and 
var gene Tu associated with missing primers were set to Tu = 1. RF binary classification models were fit 
using the R caret (86) and randomForest (87) packages to discriminate UM versus CM; UM versus CMBS+ 
(brain swelling score > 1, Supplemental Table 1); and CMBS+ versus CMBS–. For each comparison, the Tu 
values of  var transcripts and optionally PfHRP2 and platelet levels were used as continuous predictors. 
During RF training, data are randomly divided into random splits, with replacement, of  both samples and 
predictors (e.g., var transcripts, platelet levels) and decision trees fit on each subset, with the final result 
being a RF of  decision tree aggregate predictions. Initial model performance was assessed using out-of-bag 
predictions (i.e., predictions on the data held out during each random split by the decision tree trained on 
the split). Model performance was scored as the area under the receiver-operator curve (ROC AUC), with 
associated 95% CIs calculated with the pROC package in R package. Models were considered significant 
when the lower 95% CI of  AUC was greater than 0.5, where 0.5 corresponds to the expected performance 
of  a random predictor. The contribution of  individual var genes or other features to model performance 
was assessed as MDCA. The MDCA value is estimated during training as the difference in classifier accu-
racy for random splits that contain the predictor in question versus those that do not. For visualization and 
plotting purposes, where a decrease in a certain predictor was associated with a more severe outcome, a 
negatively signed MDCA score was shown. The mProbes algorithm (88) was used to identify predictors 
significantly associated with sample classes. Model cross-prediction performance was assessed by using 
models trained and parameterized on Malawi samples to make unbiased predictions on Rourkela samples, 
with ROC AUC and MDCA calculated as above.
Study approval. The study at IGH was approved by the Health Ministry Screening Committee, Government 
of India (TDR589/2010/ECDII), as well as the IRBs of IGH (IGH/DNB/2814), New York University School 
of Medicine (S12-03016), Western IRB (USA), and the London School of Hygiene & Tropical Medicine. The 
study in Malawi was approved by the IRBs at the University of Malawi College of Medicine, Michigan State 
University, and the Albert Einstein College of Medicine.
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